Little P[Author] - Search Results

Year	Number of Results
1869	1
1945	1
1948	5
1949	2
1950	1
1951	3
1953	2
1959	1
1960	2
1961	3
1962	4
1963	3
1964	3
1965	5
1966	4
1967	4
1969	3
1970	3
1971	1
1972	5
1973	3
1974	9
1975	7
1976	11
1977	7
1978	11
1979	12
1980	7
1981	8
1982	9
1983	7
1984	14
1985	9
1986	9
1987	16
1988	22
1989	13
1990	20
1991	20
1992	17
1993	14
1994	9
1995	12
1996	18
1997	17
1998	13
1999	13
2000	9
2001	18
2002	16
2003	17
2004	20
2005	23
2006	22
2007	17
2008	30
2009	30
2010	34
2011	36
2012	43
2013	46
2014	59
2015	49
2016	54
2017	60
2018	70
2019	56
2020	66
2021	75
2022	46
2023	43
2024	49
2025	43
2026	21

1

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies.

Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J. Xu S, et al. Among authors: little pj. Pharmacol Rev. 2021 Jul;73(3):924-967. doi: 10.1124/pharmrev.120.000096. Pharmacol Rev. 2021. PMID: 34088867 Review.

2

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies.

Wu X, Xu M, Geng M, Chen S, Little PJ, Xu S, Weng J. Wu X, et al. Among authors: little pj. Signal Transduct Target Ther. 2023 May 27;8(1):220. doi: 10.1038/s41392-023-01439-y. Signal Transduct Target Ther. 2023. PMID: 37244925 Free PMC article. Review.

3

Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba.

Ye W, Wang J, Little PJ, Zou J, Zheng Z, Lu J, Yin Y, Liu H, Zhang D, Liu P, Xu S, Ye W, Liu Z. Ye W, et al. Among authors: little pj. Acta Pharm Sin B. 2024 Jan;14(1):1-19. doi: 10.1016/j.apsb.2023.09.014. Epub 2023 Sep 23. Acta Pharm Sin B. 2024. PMID: 38239238 Free PMC article. Review.

4

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Butler CC, Pinto AD, Harris V, Holmes J, Rahman NM, Cureton L, Hayward G, Richards DB, Lowe DM, Standing JF, Breuer J, Hood K, Png ME, Petrou S, Dorward J, Patel MG, Thomas NPB, Evans P, Hart ND, Jani BD, Hosseini B, Murthy S, McBrien K, Condon A, McDonald EG, Daley P, Greiver M, da Costa BR, Selby P, Jüni P, Lee TC, Shi H, Detry MA, Saunders CT, Fitzgerald M, Berry NS, Saville BR, Khoo SH, Nguyen-Van-Tam JS, Hobbs FDR, Yu LM, Little P; PANORAMIC Trial and CanTreatCOVID Trial Collaborative Groups. Butler CC, et al. Among authors: little p. N Engl J Med. 2026 Apr 23;394(16):1583-1594. doi: 10.1056/NEJMoa2502457. N Engl J Med. 2026. PMID: 42019019 Free PMC article. Clinical Trial.

5

Antibiotic-perturbed microbiota and the role of probiotics.

Szajewska H, Scott KP, de Meij T, Forslund-Startceva SK, Knight R, Koren O, Little P, Johnston BC, Łukasik J, Suez J, Tancredi DJ, Sanders ME. Szajewska H, et al. Among authors: little p. Nat Rev Gastroenterol Hepatol. 2025 Mar;22(3):155-172. doi: 10.1038/s41575-024-01023-x. Epub 2024 Dec 11. Nat Rev Gastroenterol Hepatol. 2025. PMID: 39663462 Review.

6

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies.

Fang T, Wang H, Pan X, Little PJ, Xu S, Weng J. Fang T, et al. Among authors: little pj. Int J Biol Sci. 2022 Sep 6;18(15):5681-5697. doi: 10.7150/ijbs.65044. eCollection 2022. Int J Biol Sci. 2022. PMID: 36263163 Free PMC article. Review.

7

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential.

Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J, Xu S. Ma X, et al. Among authors: little pj. Int J Biol Sci. 2021 May 11;17(8):2050-2068. doi: 10.7150/ijbs.59965. eCollection 2021. Int J Biol Sci. 2021. PMID: 34131405 Free PMC article. Review.

8

Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis.

Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S, Weng J, Ge J. Jiang H, et al. Among authors: little pj. Front Cardiovasc Med. 2022 Jun 1;9:925923. doi: 10.3389/fcvm.2022.925923. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35722128 Free PMC article. Review.

9

Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.

Ni XY, Feng XJ, Wang ZH, Zhang Y, Little PJ, Cao Y, Xu SW, Tang LQ, Weng JP. Ni XY, et al. Among authors: little pj. Acta Pharmacol Sin. 2024 Aug;45(8):1604-1617. doi: 10.1038/s41401-024-01265-0. Epub 2024 Apr 8. Acta Pharmacol Sin. 2024. PMID: 38589689 Free PMC article.

10

Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial.

McManus RJ, Little P, Stuart B, Morton K, Raftery J, Kelly J, Bradbury K, Zhang J, Zhu S, Murray E, May CR, Mair FS, Michie S, Smith P, Band R, Ogburn E, Allen J, Rice C, Nuttall J, Williams B, Yardley L; HOME BP investigators. McManus RJ, et al. Among authors: little p. BMJ. 2021 Jan 19;372:m4858. doi: 10.1136/bmj.m4858. BMJ. 2021. PMID: 33468518 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,322 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,322 results

Results by year